Biocon calls US generic drug tariffs a negotiation tactic
Biocon will wait before changing its US strategy, while exploring partnerships for local manufacturing if required, executive chairperson Kiran Mazumdar-Shaw told Mint. She said proposed tariffs were more likely a negotiating threat…








































Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.